Choose your lead compound for development

Today, 90% of drug candidates in clinical trials fail to reach the market. Selecting the right target and identifying the best lead compound to improve the rates of clinical drugs entering the market is a real challenge.

Use NPOT® technology to reduce the time and cost in qualifying your compound from ‘hit’ to ‘lead’

With greater emphasis on translational pharmacology, any number of compounds can be profiled for their druggability, and we can identify within four weeks of study the lead to move forward into development.

This fast turnaround will help you significantly reduce the time and cost in qualifying a compound from ‘hit’ to ‘lead’.

Once the target has been validated for the lead compound, you can then return to the initial batch of compounds, rank them based on the identified target and keep them as back-up.

Understand the Mode of Action of your compound

Identify and validate targets

Choose your lead compound for development

Stratify different patient groups

Define the indication

Identify biomarkers

Bioanalytical services

Need Help